Vijay Satyanand Pande
CIK: 0001840663
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BioAge Labs, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 10, 2026BIOA
BioAge Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
22K shares- - Aug 7, 2025BIOA
BioAge Labs, Inc.
Award(A)DirectStock Option (Right to Buy)
22K shares- - Oct 3, 2024BIOA
BioAge Labs, Inc.
Purchase(P)Indirect25.3K shares at avg. $19.90$504K - Oct 2, 2024BIOA
BioAge Labs, Inc.
Purchase(P)Indirect67.1K shares at avg. $19.73$1.3M - Oct 1, 2024BIOA
BioAge Labs, Inc.
Purchase(P)Indirect126.8K shares at avg. $19.73$2.5M - Sep 27, 2024BIOA
BioAge Labs, Inc.
Conversion(C)Indirect856K shares- - Sep 27, 2024BIOA
BioAge Labs, Inc.
Purchase(P)Indirect900K shares at avg. $18.00$16.2M - Sep 27, 2024BIOA
BioAge Labs, Inc.
Conversion(C)Indirect655.3K shares- - Sep 27, 2024BIOA
BioAge Labs, Inc.
Conversion(C)Indirect189.6K shares- - Sep 27, 2024BIOA
BioAge Labs, Inc.
Conversion(C)Indirect413.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | BIOA BioAge Labs, Inc. | Award(A) Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Aug 7, 2025 | BIOA BioAge Labs, Inc. | Award(A) Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| Oct 3, 2024 | BIOA BioAge Labs, Inc. | Purchase(P) | 25,306 | $19.90 | $503,589 | Indirect |
| Oct 2, 2024 | BIOA BioAge Labs, Inc. | Purchase(P) | 67,096 | $19.73 | $1,323,804 | Indirect |
| Oct 1, 2024 | BIOA BioAge Labs, Inc. | Purchase(P) | 126,793 | $19.73 | $2,501,626 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion(C) | 855,972 | - | $0 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Purchase(P) | 900,000 | $18.00 | $16,200,000 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion(C) | 655,294 | - | $0 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion(C) | 189,609 | - | $0 | Indirect |
| Sep 27, 2024 | BIOA BioAge Labs, Inc. | Conversion(C) | 413,100 | - | $0 | Indirect |
1-10 of 10 transactions
About Pande Vijay Satyanand
Pande Vijay Satyanand (SEC CIK 0001840663) files insider reports with the SEC as Director of BioAge Labs, Inc. (BIOA).
Signal8 holds 5 ownership filings by Pande Vijay Satyanand (1 Form 3, 4 Form 4), filed between Sep 25, 2024 and Jun 12, 2026. Those filings report 10 transactions, from Sep 27, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pande Vijay Satyanand's filings is in EMERYVILLE, CA.
Recent filings by Pande Vijay Satyanand
- Jun 10, 2026: Grant or award of BIOA derivative securities (Form 4, code A).
- Aug 7, 2025: Grant or award of BIOA derivative securities (Form 4, code A).
- Oct 3, 2024: Open-market purchase of BIOA shares (Form 4, code P).
- Oct 2, 2024: Open-market purchase of BIOA shares (Form 4, code P).
- Oct 1, 2024: Open-market purchase of BIOA shares (Form 4, code P).
Other insiders filing for BioAge Labs, Inc. (BIOA)
- Barton Shane, Principal Accounting Officer
- Hemrajani Rekha, Director
- HEALY JAMES, Director
- ENRIGHT PATRICK G, Director
- Davidson Michael H., Director
- GARNIER JEAN PIERRE, Director